Provided by Tiger Trade Technology Pte. Ltd.

Magenta Therapeutics Inc.

11.19
0.0000
Volume:- -
Turnover:268.84K
Market Cap:42.24M
PE:-0.61
High:11.19
Open:11.19
Low:11.19
Close:11.19
52wk High:35.49
52wk Low:5.14
Shares:3.77M
Float Shares:2.10M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.2297
EPS(LYR):-20.6054
ROE:-65.34%
ROA:-28.85%
PB:0.57
PE(LYR):-0.54

Loading ...

Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 30, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 02, 2022

Major Issues Report

8-K - Current report
Apr 14, 2022

Major Issues Report

8-K - Current report
Mar 08, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 08, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 08, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Nov 04, 2021

Major Issues Report

8-K - Current report
Nov 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2021

Major Issues Report

8-K - Current report